Recombinant CrkL 抗体 (pTyr207)
Our Local Distributor
北京 101111
Quick Overview for Recombinant CrkL 抗体 (pTyr207) (ABIN7879829)
抗原
See all CrkL (CRKL) 抗体抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- pTyr207
-
原理
- Phospho-CrkL (Tyr207) Antibody / Crk like protein
-
纯化方法
- Affinity chromatography
-
免疫原
- A synthesized peptide derived from human Phospho-CrkL (Y207) was used as the immunogen for the Phospho-CrkL (Tyr207) antibody.
-
亚型
- IgG
-
-
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (AA 1-303) antibody
CRKL 适用: 人 WB, IF, PLA 宿主: 兔 Polyclonal unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (AA 204-303) antibodyCRKL 适用: 人 WB, ELISA, IF, PLA, RNAi 宿主: 小鼠 Monoclonal 4B5 unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) antibodyCRKL 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 5E12 unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (pTyr251) antibodyCRKL 适用: 人, 小鼠 WB, ELISA, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (AA 1-303) antibodyCRKL 适用: 人 WB, IHC, ICC, IP 宿主: 兔 Polyclonal unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) antibodyKD Validated CRKL 适用: 人 WB, FACS 宿主: 兔 Monoclonal 23GB4735 unconjugated Recombinant Antibody
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (AA 201-303) antibodyCRKL 适用: 小鼠 ELISA, IF (cc), IF (p), IHC (p), IHC (fro) 宿主: 兔 Polyclonal unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (C-Term) antibodyVerified CRKL 适用: 人, 小鼠 WB, ELISA, IHC, IF, FACS 宿主: 山羊 Polyclonal unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (AA 1-303) antibodyCRKL 适用: 人 WB, IF 宿主: 小鼠 Polyclonal unconjugated
anti-V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL) (AA 98-303) antibodyCRKL 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal dilution of the Phospho-CrkL (Tyr207) antibody should be determined by the researcher.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Rabbit IgG in phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol, 0.4-0.5 mg/mL BSA
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store the Phospho-CrkL (Tyr207) antibody at -20oC.
-
-
- CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))
-
别名
- CrkL
-
背景
-
Phospho-CrkL (Tyr207) antibody detects the phosphorylated form of Crk like protein, encoded by the CRKL gene. Crk like is an adaptor protein that mediates intracellular signaling downstream of multiple tyrosine kinases, including BCR ABL, EGFR, and PDGFR. It contains SH2 and SH3 domains that allow it to bind phosphotyrosine residues and recruit effector proteins, thereby linking receptor activation to downstream pathways. Phosphorylation at tyrosine 207 is a regulatory modification that influences Crk like protein interactions and signaling capacity. Phospho-CrkL (Tyr207) antibody provides researchers with a reliable reagent to study tyrosine kinase signaling in normal and malignant cells.
Crk like phosphorylation at tyrosine 207 is mediated by kinases such as ABL and has been shown to modulate protein conformation and adaptor activity. Research using Phospho-CrkL (Tyr207) antibody has demonstrated that phosphorylation reduces binding to certain partners while promoting interactions with negative regulators, thus acting as a feedback mechanism to control signaling intensity. This fine tuning ensures that pathways such as Ras, Rac, and PI3K are activated appropriately in response to growth factor stimulation or stress signals.
Aberrant phosphorylation of Crk like at tyrosine 207 has been strongly associated with leukemia, particularly chronic myeloid leukemia, where BCR ABL fusion kinase constitutively phosphorylates this residue. Phospho-CrkL (Tyr207) antibody has therefore become a surrogate marker for BCR ABL activity in both research and clinical contexts. Monitoring Crk like phosphorylation provides a sensitive measure of kinase inhibition in patients treated with tyrosine kinase inhibitors, making it a valuable biomarker for therapeutic response. Beyond leukemia, altered phosphorylation has been observed in solid tumors, linking Crk like to diverse oncogenic pathways.
Phospho-CrkL (Tyr207) antibody is used in western blotting, immunoprecipitation, and flow cytometry. Western blotting provides detection of phosphorylated protein as an indicator of kinase activity. Immunoprecipitation with this antibody isolates Crk like protein complexes, allowing characterization of binding partners under different phosphorylation states. Flow cytometry applications extend its use to patient samples, where phosphorylation levels can be measured at the single cell level. These diverse applications demonstrate the versatility of Phospho-CrkL (Tyr207) antibody in both laboratory research and translational medicine.
By providing Phospho-CrkL (Tyr207) antibody, NSJ Bioreagents supports research into tyrosine kinase signaling, cancer biology, and therapeutic monitoring. Detection of Crk like phosphorylation at tyrosine 207 offers a powerful means of understanding adaptor protein regulation and its impact on cellular behavior. -
UniProt
- P46109
-
途径
- Interferon-gamma Pathway, Neurotrophin Signaling Pathway, Signaling of Hepatocyte Growth Factor Receptor
抗原
-
